Method Development for Structural Assessment of Nanolipoprotein
Particles with and without Cross-linked Lipids
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Abstract

Results
NLP Purification and Characterization
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Future Directions
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Analysis of High-Throughput Crystallization Screens

Cell-free Production and Crystallization of NLPs

X-NLP Crystals

I was able to produce mg-scale amounts of purified X-NLPs through
cell-free expression and UV cross-linking, and I characterized their size
distribution and confirmed nanoparticle formation by size exclusion
chromatography and dynamic light scattering. I also identified chemical
conditions that promote DMPC NLP and X-NLP crystal growth and
subsequently validated those conditions for X-NLPs and optimized
conditions for DMPC NLPs at LLNL. The X-NLP crystals are
significantly larger and more uniform than those of the noncross-linked
NLPs, suggesting that they may have superior diffraction quality for Xray crystallography. This work has advanced our current knowledge
of X-NLPs and improved methods for readily crystallizing NLPs.
This work also represents the first instance of verified crystallization
of cross-linked NLPs.
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The NLP belt protein ApoA1 contains a 6xHis-tag. Approximately 1.6 mg of 20% Diyne NLPs were produced by cell
free expression and purified by Ni affinity. This yielded a population of X-NLPs that is mostly homogenous in size
and is indistinguishable in size from DMPC NLPs, as characterized by SEC and DLS.
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Membrane proteins make up approximately 30% of the cellular proteome
and account for over 60% of pharmaceutical targets.1 Determining the
structures of this class of proteins is critical to our understanding of
disease states and will advance rational drug design. But membrane
proteins have limited solubility, rarely form large crystals that diffract well,
and often misfold outside of a bilayer, hindering crystallographic studies.1
Nanolipoprotein particles (NLPs) have arisen as a platform to readily
solubilize membrane proteins while mimicking a native lipid environment.
NLPs consist of a discoidal phospholipid bilayer encircled by an
apolipoprotein belt. In an effort to optimize and improve crystallization of
empty NLPs, we altered the fluidity of the lipid bilayer by incorporating
photoactive DiynePC phospholipids in the lipid bilayer, forming crosslinked nanoparticles (X-NLPs). Here, we used a cell-free expression
system with apolipoprotein A1 (ApoA1) plasmid and micellar lipids to
assemble NLPs. Based on high throughput crystallization screening
data, we reproduced and validated crystallization conditions for X-NLPs
and optimized conditions for non-crosslinked NLPs (DMPC NLPs).

Conclusion

Chemical conditions of crystallization hits from high throughput screens were
analyzed to determine which conditions were optimal for crystal formation. These
conditions include parameters such as buffer, pH, salt composition, and
polyethylene glycol (PEG) molecular weight and concentration.

The methods developed in this study will be used to grow microcrystals
of DMPC NLPs and X-NLPs for use in serial femtosecond
crystallography using XFELs. X-NLPs may have improved diffraction
quality compared to DMPC NLPs, which could afford more exact
structural determinations of empty NLPs. Future researchers can build
off of this study to optimize conditions for crystallizing membrane
proteins embedded in NLPs. This will open up possibilities for structural
studies of membrane proteins with potentially exciting therapeutic
applications, such as the chlamydial major outer membrane protein
(MOMP), which is a promising candidate for a chlamydia vaccine.
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Validation and Optimization of Crystallization Conditions at LLNL
Adapted from Gilmore et al.2

Crystallization screens were performed
using vapor diffusion and microbatch
plates. These methods allow for slow,
controlled crystal growth.
Microbatch plate (under oil)
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NLPs self-assemble when the Apo1 belt
protein is expressed in the presence of lipid
vesicles via a cell-free expression system.
X-NLPs are produced using an 80:20
DMPC:DiynePC lipid mixture and are then
exposed to UV to cross-link the lipids.
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Crystallization conditions of interest were selected,
each containing salt, buffer, and polyethylene glycol.
These conditions were screened on vapor diffusion
and microbatch plates. DMPC NLP crystals were
observed after 5 days, and X-NLP crystals were
observed after 12 days. X-NLP were successfully
crystallized using 0.1 M potassium carbonate, 0.1 M
CAPS buffer pH 10, and 39% (w/v) PEG 4000. X-NLP
crystals were approximately 70 μm long.

Serial Femtosecond
Crystallography with XFELs

MOMP in an NLP*
*Artistic representation.
PDB: 3POX
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